Healthy adults needed to test new drug safety in Early-Stage trial
NCT ID NCT07364851
First seen Jan 27, 2026 · Last updated May 17, 2026 · Updated 22 times
Summary
This early-stage trial will test the safety and how the body processes two experimental drugs, DW4421-T1 and DW4421S-T1, in 38 healthy adults aged 19 to 50. Participants will receive a single dose of each drug in a random order, with a break in between. The study does not aim to treat any disease, but to gather important safety information before further testing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chungbuk National University Hospital
Cheongju-si, South Korea
Conditions
Explore the condition pages connected to this study.